| Authors: |
du Chatinier A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Meel MH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Das AI; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Metselaar DS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Waranecki P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bugiani M; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Breur M; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Simonds EF; Departments of Neurology, Neurological Surgery, and Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Lu ED; Departments of Neurology, Neurological Surgery, and Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Weiss WA; Departments of Neurology, Neurological Surgery, and Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Garcia Vallejo JJ; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Hoving EW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Phoenix TN; Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati/Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. |
